GeneDx Holdings Corp. ($WGS)
Filing Information
| Accession Number | 0001944119-26-000011 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 5, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
32,314
Total Value
$486,370.14
P&L
+inf% (+$1,824,709.68)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF FINANCIAL OFFICER | Class A Common Stock | โ | Mar 3, 2026 | Grant/Award | 15,262 | $0.00 | $0.00 | 24,861 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Class A Common Stock | โ | Mar 4, 2026 | Sale | 1,424 | $77.63 | $110,539.57 | 23,437 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Class A Common Stock | โ | Mar 4, 2026 | Sale | 2,543 | $78.61 | $199,897.35 | 20,894 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Class A Common Stock | โ | Mar 4, 2026 | Sale | 2,220 | $79.25 | $175,933.22 | 18,674 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Restricted Stock Unit | Derivative | Mar 3, 2026 | Grant/Award | 10,865 | $0.00 | $0.00 | 10,865 | Direct | โ | View Details |